Amyloid precursor protein controls cholesterol turnover needed for neuronal activity

Perturbation of lipid metabolism favours progression of Alzheimer disease, in which processing of Amyloid Precursor Protein (APP) has important implications. APP cleavage is tightly regulated by cholesterol and APP fragments regulate lipid homeostasis. Here, we investigated whether up or down regula...

Full description

Bibliographic Details
Main Authors: Pierrot, Nathalie, Tyteca, Donatienne, D'auria, Ludovic, Dewachter, Ilse, Gailly, Philippe, Hendrickx, Aurélie, Tasiaux, Bernadette, Haylani, Laetitia El, Muls, Nathalie, N'Kuli, Francisca, Laquerrière, Annie, Demoulin, Jean-Baptiste, Campion, Dominique, Brion, Jean-Pierre, Courtoy, Pierre J, Kienlen-Campard, Pascal, Octave, Jean-Noël
Format: Online
Language:English
Published: WILEY-VCH Verlag 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3628100/
id pubmed-3628100
recordtype oai_dc
spelling pubmed-36281002013-04-19 Amyloid precursor protein controls cholesterol turnover needed for neuronal activity Pierrot, Nathalie Tyteca, Donatienne D'auria, Ludovic Dewachter, Ilse Gailly, Philippe Hendrickx, Aurélie Tasiaux, Bernadette Haylani, Laetitia El Muls, Nathalie N'Kuli, Francisca Laquerrière, Annie Demoulin, Jean-Baptiste Campion, Dominique Brion, Jean-Pierre Courtoy, Pierre J Kienlen-Campard, Pascal Octave, Jean-Noël Research Articles Perturbation of lipid metabolism favours progression of Alzheimer disease, in which processing of Amyloid Precursor Protein (APP) has important implications. APP cleavage is tightly regulated by cholesterol and APP fragments regulate lipid homeostasis. Here, we investigated whether up or down regulation of full-length APP expression affected neuronal lipid metabolism. Expression of APP decreased HMG-CoA reductase (HMGCR)-mediated cholesterol biosynthesis and SREBP mRNA levels, while its down regulation had opposite effects. APP and SREBP1 co-immunoprecipitated and co-localized in the Golgi. This interaction prevented Site-2 protease-mediated processing of SREBP1, leading to inhibition of transcription of its target genes. A GXXXG motif in APP sequence was critical for regulation of HMGCR expression. In astrocytes, APP and SREBP1 did not interact nor did APP affect cholesterol biosynthesis. Neuronal expression of APP decreased both HMGCR and cholesterol 24-hydroxylase mRNA levels and consequently cholesterol turnover, leading to inhibition of neuronal activity, which was rescued by geranylgeraniol, generated in the mevalonate pathway, in both APP expressing and mevastatin treated neurons. We conclude that APP controls cholesterol turnover needed for neuronal activity. WILEY-VCH Verlag 2013-04 2013-04-02 /pmc/articles/PMC3628100/ /pubmed/23554170 http://dx.doi.org/10.1002/emmm.201202215 Text en Copyright © 2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO http://creativecommons.org/licenses/by/2.5/ This is an open access article under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Pierrot, Nathalie
Tyteca, Donatienne
D'auria, Ludovic
Dewachter, Ilse
Gailly, Philippe
Hendrickx, Aurélie
Tasiaux, Bernadette
Haylani, Laetitia El
Muls, Nathalie
N'Kuli, Francisca
Laquerrière, Annie
Demoulin, Jean-Baptiste
Campion, Dominique
Brion, Jean-Pierre
Courtoy, Pierre J
Kienlen-Campard, Pascal
Octave, Jean-Noël
spellingShingle Pierrot, Nathalie
Tyteca, Donatienne
D'auria, Ludovic
Dewachter, Ilse
Gailly, Philippe
Hendrickx, Aurélie
Tasiaux, Bernadette
Haylani, Laetitia El
Muls, Nathalie
N'Kuli, Francisca
Laquerrière, Annie
Demoulin, Jean-Baptiste
Campion, Dominique
Brion, Jean-Pierre
Courtoy, Pierre J
Kienlen-Campard, Pascal
Octave, Jean-Noël
Amyloid precursor protein controls cholesterol turnover needed for neuronal activity
author_facet Pierrot, Nathalie
Tyteca, Donatienne
D'auria, Ludovic
Dewachter, Ilse
Gailly, Philippe
Hendrickx, Aurélie
Tasiaux, Bernadette
Haylani, Laetitia El
Muls, Nathalie
N'Kuli, Francisca
Laquerrière, Annie
Demoulin, Jean-Baptiste
Campion, Dominique
Brion, Jean-Pierre
Courtoy, Pierre J
Kienlen-Campard, Pascal
Octave, Jean-Noël
author_sort Pierrot, Nathalie
title Amyloid precursor protein controls cholesterol turnover needed for neuronal activity
title_short Amyloid precursor protein controls cholesterol turnover needed for neuronal activity
title_full Amyloid precursor protein controls cholesterol turnover needed for neuronal activity
title_fullStr Amyloid precursor protein controls cholesterol turnover needed for neuronal activity
title_full_unstemmed Amyloid precursor protein controls cholesterol turnover needed for neuronal activity
title_sort amyloid precursor protein controls cholesterol turnover needed for neuronal activity
description Perturbation of lipid metabolism favours progression of Alzheimer disease, in which processing of Amyloid Precursor Protein (APP) has important implications. APP cleavage is tightly regulated by cholesterol and APP fragments regulate lipid homeostasis. Here, we investigated whether up or down regulation of full-length APP expression affected neuronal lipid metabolism. Expression of APP decreased HMG-CoA reductase (HMGCR)-mediated cholesterol biosynthesis and SREBP mRNA levels, while its down regulation had opposite effects. APP and SREBP1 co-immunoprecipitated and co-localized in the Golgi. This interaction prevented Site-2 protease-mediated processing of SREBP1, leading to inhibition of transcription of its target genes. A GXXXG motif in APP sequence was critical for regulation of HMGCR expression. In astrocytes, APP and SREBP1 did not interact nor did APP affect cholesterol biosynthesis. Neuronal expression of APP decreased both HMGCR and cholesterol 24-hydroxylase mRNA levels and consequently cholesterol turnover, leading to inhibition of neuronal activity, which was rescued by geranylgeraniol, generated in the mevalonate pathway, in both APP expressing and mevastatin treated neurons. We conclude that APP controls cholesterol turnover needed for neuronal activity.
publisher WILEY-VCH Verlag
publishDate 2013
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3628100/
_version_ 1611970524349464576